These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 10873081

  • 1. Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer.
    Cvijic ME, Kita T, Shih W, DiPaola RS, Chin KV.
    Clin Cancer Res; 2000 Jun; 6(6):2309-17. PubMed ID: 10873081
    [Abstract] [Full Text] [Related]

  • 2. Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker.
    Cho YS, Lee YN, Cho-Chung YS.
    Biochem Biophys Res Commun; 2000 Nov 30; 278(3):679-84. PubMed ID: 11095968
    [Abstract] [Full Text] [Related]

  • 3. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M, Noguchi K, Park YG, Lee YN, Cho-Chung YS.
    Clin Cancer Res; 2000 Sep 30; 6(9):3434-41. PubMed ID: 10999726
    [Abstract] [Full Text] [Related]

  • 4. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV, Cho-Chung YS.
    Clin Cancer Res; 2004 Jul 01; 10(13):4568-77. PubMed ID: 15240549
    [Abstract] [Full Text] [Related]

  • 5. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
    Cho YS, Cho-Chung YS.
    Clin Cancer Res; 2003 Mar 01; 9(3):1171-8. PubMed ID: 12631623
    [Abstract] [Full Text] [Related]

  • 6. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.
    Clin Cancer Res; 2002 Feb 01; 8(2):607-14. PubMed ID: 11839683
    [Abstract] [Full Text] [Related]

  • 7. Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants.
    Cvijic ME, Chin KV.
    Cell Growth Differ; 1997 Dec 01; 8(12):1243-7. PubMed ID: 9419412
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The enterocyte-like differentiation of the Caco-2 tumor cell line strongly correlates with responsiveness to cAMP and activation of kinase A pathway.
    Pignata S, Maggini L, Zarrilli R, Rea A, Acquaviva AM.
    Cell Growth Differ; 1994 Sep 01; 5(9):967-73. PubMed ID: 7819134
    [Abstract] [Full Text] [Related]

  • 10. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
    Nesterova MV, Cho-Chung YS.
    Ann N Y Acad Sci; 2005 Nov 01; 1058():255-64. PubMed ID: 16394142
    [Abstract] [Full Text] [Related]

  • 11. Nuclear localization of type II cAMP-dependent protein kinase during limb cartilage differentiation is associated with a novel developmentally regulated A-kinase anchoring protein.
    Zhang Q, Carr DW, Lerea KM, Scott JD, Newman SA.
    Dev Biol; 1996 May 25; 176(1):51-61. PubMed ID: 8654894
    [Abstract] [Full Text] [Related]

  • 12. Alpha4 integrins are type I cAMP-dependent protein kinase-anchoring proteins.
    Lim CJ, Han J, Yousefi N, Ma Y, Amieux PS, McKnight GS, Taylor SS, Ginsberg MH.
    Nat Cell Biol; 2007 Apr 25; 9(4):415-21. PubMed ID: 17369818
    [Abstract] [Full Text] [Related]

  • 13. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.
    Chung S, Furihata M, Tamura K, Uemura M, Daigo Y, Nasu Y, Miki T, Shuin T, Fujioka T, Nakamura Y, Nakagawa H.
    Oncogene; 2009 Aug 13; 28(32):2849-59. PubMed ID: 19483721
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation.
    Manna PR, Chandrala SP, Jo Y, Stocco DM.
    J Mol Endocrinol; 2006 Aug 13; 37(1):81-95. PubMed ID: 16901926
    [Abstract] [Full Text] [Related]

  • 17. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit.
    Neary CL, Cho-Chung YS.
    Oncogene; 2001 Nov 29; 20(55):8019-24. PubMed ID: 11753685
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of substrate on type I and type II PKA holoenzyme dissociation.
    Vigil D, Blumenthal DK, Brown S, Taylor SS, Trewhella J.
    Biochemistry; 2004 May 18; 43(19):5629-36. PubMed ID: 15134437
    [Abstract] [Full Text] [Related]

  • 19. Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells.
    Deeble PD, Cox ME, Frierson HF, Sikes RA, Palmer JB, Davidson RJ, Casarez EV, Amorino GP, Parsons SJ.
    Cancer Res; 2007 Apr 15; 67(8):3663-72. PubMed ID: 17440078
    [Abstract] [Full Text] [Related]

  • 20. PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells.
    Obara Y, Labudda K, Dillon TJ, Stork PJ.
    J Cell Sci; 2004 Dec 01; 117(Pt 25):6085-94. PubMed ID: 15546918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.